Bank of America’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-394,312
| Closed | -$26.7M | – | 7693 |
|
|
2019
Q3 | $26.7M | Buy |
394,312
+189,230
| +92% | +$13M | ﹤0.01% | 1584 |
|
|
2019
Q2 | $11.9M | Sell |
205,082
-54,322
| -21% | -$3.22M | ﹤0.01% | 2358 |
|
|
2019
Q1 | $18.2M | Buy |
259,404
+108,940
| +72% | +$8.08M | ﹤0.01% | 1911 |
|
|
2018
Q4 | $9.69M | Buy |
150,464
+50,806
| +51% | +$3.56M | ﹤0.01% | 2333 |
|
|
2018
Q3 | $7M | Sell |
99,658
-6,468
| -6% | -$378K | ﹤0.01% | 2869 |
|
|
2018
Q2 | $5.35M | Sell |
106,126
-43,147
| -29% | -$1.71M | ﹤0.01% | 3092 |
|
|
2018
Q1 | $4.67M | Buy |
149,273
+9,150
| +7% | +$304K | ﹤0.01% | 3151 |
|
|
2017
Q4 | $4.79M | Buy |
140,123
+1,489
| +1% | +$47.5K | ﹤0.01% | 3163 |
|
|
2017
Q3 | $4.45M | Buy |
138,634
+42,246
| +44% | +$1.33M | ﹤0.01% | 3287 |
|
|
2017
Q2 | $3.14M | Buy |
96,388
+82,677
| +603% | +$2.62M | ﹤0.01% | 3481 |
|
|
2017
Q1 | $432K | Buy |
13,711
+2,794
| +26% | +$82.7K | ﹤0.01% | 4964 |
|
|
2016
Q4 | $321K | Buy |
10,917
+3,050
| +39% | +$93K | ﹤0.01% | 5080 |
|
|
2016
Q3 | $227K | Sell |
7,867
-5,881
| -43% | -$164K | ﹤0.01% | 5060 |
|
|
2016
Q2 | $355K | Buy |
13,748
+8,889
| +183% | +$236K | ﹤0.01% | 4881 |
|
|
2016
Q1 | $121K | Sell |
4,859
-9,649
| -67% | -$265K | ﹤0.01% | 5389 |
|
|
2015
Q4 | $511K | Buy |
14,508
+627
| +5% | +$16.8K | ﹤0.01% | 4812 |
|
|
2015
Q3 | $294K | Sell |
13,881
-20,471
| -60% | -$528K | ﹤0.01% | 5131 |
|
|
2015
Q2 | $954K | Buy |
34,352
+28,055
| +446% | +$791K | ﹤0.01% | 4154 |
|
|
2015
Q1 | $192K | Sell |
6,297
-8,612
| -58% | -$274K | ﹤0.01% | 4952 |
|
|
2014
Q4 | $477K | Buy |
14,909
+6,271
| +73% | +$204K | ﹤0.01% | 4659 |
|
|
2014
Q3 | $245K | Sell |
8,638
-19,033
| -69% | -$531K | ﹤0.01% | 5210 |
|
|
2014
Q2 | $758K | Sell |
27,671
-19,394
| -41% | -$516K | ﹤0.01% | 4229 |
|
|
2014
Q1 | $1.24M | Buy |
47,065
+355
| +0.8% | +$10.2K | ﹤0.01% | 3676 |
|
|
2013
Q4 | $1.37M | Sell |
46,710
-768
| -2% | -$24.4K | ﹤0.01% | 3721 |
|
|
2013
Q3 | $1.45M | Sell |
47,478
-5,779
| -11% | -$193K | ﹤0.01% | 3580 |
|
|
2013
Q2 | $1.69M | Buy |
+53,257
| New | +$1.75M | ﹤0.01% | 3423 |
|
Bank of America's GHDX Position: Q4 2019 in Review
Bank of America sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 394,312 shares — an estimated $26.7M sold.
Bank of America first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $26.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Bank of America reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 394,312 Genomic Health, Inc. shares in Q4 2019, an estimated $26.7M.
- Bank of America first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Bank of America's Genomic Health, Inc. position peaked at $26.7M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.